目次

Contents

1. Executive Summary

2. Global Stem cell therapy Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms

3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation

4. Average Pricing Analysis

5. Macro-Economic Indicators

6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends

7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix

8. Recent Development, Policies & Regulatory Landscape

9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis

10. Global Stem cell therapy Market Analysis
10.1. Porter Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological

11. Global Stem cell therapy Market
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F

12. Global Stem cell therapy Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. the Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By Type: Market Share (2020-2031F)
12.2.1. Adipose Tissue-Derived Mesenchymal Stem Cells, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Bone Marrow-Derived Mesenchymal Stem Cells, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.3. Embryonic Stem Cells, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.4. Others, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F

13. By Technology: Market Share (2020-2031F)
13.1. Cell Acquisition, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13.2. Cell Production, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13.3. Cryopreservation, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F

14. By Application: Market Share (2020-2031F)

15. Musculoskeletal Disorders, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 201-2031F

16. Wounds and Injuries, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-203F

17. Cardiovascular Diseases, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 20212031F

18. Surgeries, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F

19. Gastrointestinal Diseases, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 201-2031F
19.1. Others, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F

20. Company Profile
20.1. Osiris
20.1.1. Company Overview
20.1.2. Company Total Revenue (Financials)
20.1.3. Market Potential
20.1.4. Global Presence
20.1.5. Key Performance Indicators
20.1.6. SWOT Analysis
20.1.7. Product Launch
20.2. Lineage Cell Therapeutics, Inc.
20.3. Takara Bio Inc.
20.4. Thermo Fisher Scientific Inc.
20.5. Astellas Pharma Inc.
20.6. Athersys, Inc.,
20.7. Cytori Therapeutics Inc.
20.8. Fate Therapeutics
20.9. ReNeuron Group plc
20.10. Other Prominent Players

21. Consultant Recommendation
21.1.1. The above-given segmentation and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.